Jazz Pharmaceuticals plc Available-for-sale Securities, Gross Unrealized Gain
Jazz Pharmaceuticals plc (JAZZ) reported Available-for-sale Securities, Gross Unrealized Gain of $0 for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-04.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2014-11-04
- Jazz Pharmaceuticals plc available-for-sale securities, gross unrealized gain for the quarter ending 2014-03-31 was $0.00.
- Jazz Pharmaceuticals plc available-for-sale securities, gross unrealized gain for fiscal 2012 was $0.00.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month |
|---|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-04 | ||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 | ||
| 2013-12-31 | $0.00 10-Q · filed 2014-11-04 | ||
| 2012-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |